KalVista Pharma (NASDAQ:KALV) will release its quarterly earnings report on Thursday, 2025-09-11. Here’s a brief overview for investors ahead of the announcement.
Analysts anticipate KalVista Pharma to report an earnings per share (EPS) of $-0.94.
KalVista Pharma bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should …